A detailed history of First Horizon Advisors, Inc. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 142 shares of ANIP stock, worth $9,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142
Holding current value
$9,042
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$54.2 - $69.69 $7,696 - $9,895
142 New
142 $9,000
Q3 2023

Oct 27, 2023

SELL
$50.28 - $64.61 $1,659 - $2,132
-33 Reduced 18.44%
146 $8,000
Q2 2023

Aug 03, 2023

BUY
$37.29 - $53.83 $6,674 - $9,635
179 New
179 $9,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.11B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.